Search Results - "Valvezan, Alexander J."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome by Menon, Suchithra, Dibble, Christian C., Talbott, George, Hoxhaj, Gerta, Valvezan, Alexander J., Takahashi, Hidenori, Cantley, Lewis C., Manning, Brendan D.

    Published in Cell (13-02-2014)
    “…mTORC1 promotes cell growth in response to nutrients and growth factors. Insulin activates mTORC1 through the PI3K-Akt pathway, which inhibits the…”
    Get full text
    Journal Article
  2. 2

    The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals by Torrence, Margaret E, MacArthur, Michael R, Hosios, Aaron M, Valvezan, Alexander J, Asara, John M, Mitchell, James R, Manning, Brendan D

    Published in eLife (01-03-2021)
    “…The mechanistic target of rapamycin complex 1 (mTORC1) stimulates a coordinated anabolic program in response to growth-promoting signals. Paradoxically, recent…”
    Get full text
    Journal Article
  3. 3

    GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder by Valvezan, Alexander J, Klein, Peter S

    Published in Frontiers in molecular neuroscience (01-01-2012)
    “…The canonical Wnt signaling pathway is critical for development of the mammalian central nervous system and regulates diverse processes throughout adulthood,…”
    Get full text
    Journal Article
  4. 4

    mTORC1 activity oscillates throughout the cell cycle, promoting mitotic entry and differentially influencing autophagy induction by Joshi, Jay N., Lerner, Ariel D., Scallo, Frank, Grumet, Alexandra N., Matteson, Paul, Millonig, James H., Valvezan, Alexander J.

    Published in Cell reports (Cambridge) (27-08-2024)
    “…Mechanistic Target of Rapamycin Complex 1 (mTORC1) is a master metabolic regulator that is active in nearly all proliferating eukaryotic cells; however, it is…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish by Valvezan, Alexander J, Huang, Jian, Lengner, Christopher J, Pack, Michael, Klein, Peter S

    Published in Disease models & mechanisms (01-01-2014)
    “…Truncating mutations in adenomatous polyposis coli (APC) are strongly linked to colorectal cancers. APC is a negative regulator of the Wnt pathway and…”
    Get full text
    Journal Article
  7. 7

    Molecular logic of mTORC1 signalling as a metabolic rheostat by Valvezan, Alexander J., Manning, Brendan D.

    Published in Nature metabolism (01-03-2019)
    “…The protein kinase complex mechanistic target of rapamycin complex 1 (mTORC1) serves as a key conduit between growth signals and the metabolic processes…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Adenomatous Polyposis Coli (APC) Regulates Multiple Signaling Pathways by Enhancing Glycogen Synthase Kinase-3 (GSK-3) Activity by Valvezan, Alexander J., Zhang, Fang, Diehl, J. Alan, Klein, Peter S.

    Published in The Journal of biological chemistry (03-02-2012)
    “…Glycogen synthase kinase-3 (GSK-3) is essential for many signaling pathways and cellular processes. As Adenomatous Polyposis Coli (APC) functions in many of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    A review of trilaciclib, a first-in-class cyclin-dependent kinase 4/6 inhibitor, for the management of metastatic small-cell lung cancer by Patel, Twinkle I., Joshi, Jay N., Valvezan, Alexander J., Moschitto, Matthew J.

    Published in Medicinal chemistry research (01-10-2024)
    “…Cyclin-dependent kinases (CDKs) play a major role in regulating transitions within the cell cycle. Given the roles of CDK4/6 in promoting oncogenesis,…”
    Get full text
    Journal Article
  13. 13

    Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice by O'Brien, W Timothy, Huang, Jian, Buccafusca, Roberto, Garskof, Julie, Valvezan, Alexander J, Berry, Gerard T, Klein, Peter S

    Published in The Journal of clinical investigation (01-09-2011)
    “…Lithium is the first-line therapy for bipolar disorder. However, its therapeutic target remains controversial. Candidates include inositol monophosphatases,…”
    Get full text
    Journal Article
  14. 14

    Improved detection of synthetic lethal interactions in Drosophila cells using variable dose analysis (VDA) by Housden, Benjamin E., Li, Zhongchi, Kelley, Colleen, Wang, Yuanli, Hu, Yanhui, Valvezan, Alexander J., Manning, Brendan D., Perrimon, Norbert

    “…Synthetic sick or synthetic lethal (SS/L) screens are a powerful way to identify candidate drug targets to specifically kill tumor cells, but this approach…”
    Get full text
    Journal Article
  15. 15

    Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R by Filippakis, Harilaos, Alesi, Nicola, Ogorek, Barbara, Nijmeh, Julie, Khabibullin, Damir, Gutierrez, Catherine, Valvezan, Alexander J, Cunningham, James, Priolo, Carmen, Henske, Elizabeth P

    Published in Oncotarget (13-06-2017)
    “…Tuberous sclerosis complex (TSC) is a multisystem disease associated with hyperactive mTORC1. The impact of TSC1/2 deficiency on lysosome-mediated processes is…”
    Get full text
    Journal Article
  16. 16

    IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex by Valvezan, Alexander J, McNamara, Molly C, Miller, Spencer K, Torrence, Margaret E, Asara, John M, Henske, Elizabeth P, Manning, Brendan D

    Published in JCI insight (09-04-2020)
    “…Recent studies in distinct preclinical tumor models have established the nucleotide synthesis enzyme inosine-5'-monophosphate dehydrogenase (IMPDH) as a viable…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Glycogen synthase kinase-3 is essential for [Beta]-arrestin-2 complex formation and lithium-sensitive behaviors in mice by O'Brien, W Timothy, Huang, Jian, Buccafusca, Roberto, Garskof, Julie, Valvezan, Alexander J, Berry, Gerard T, Klein, Peter S

    Published in The Journal of clinical investigation (01-09-2011)
    “…Lithium is the first-line therapy for bipolar disorder. However, its therapeutic target remains controversial. Candidates include inositol monophosphatases,…”
    Get full text
    Journal Article
  19. 19

    Novel roles for the tumor suppressor APC through regulation of GSK-3 by Valvezan, Alexander J

    Published 01-01-2013
    “…Adenomatous Polyposis Coli (APC) is a tumor suppressor and essential negative regulator of the Wnt signaling pathway. Wnt signaling is crucial for proper…”
    Get full text
    Dissertation